The human protein disulfide isomerase gene family
<p>Abstract</p> <p>Enzyme-mediated disulfide bond formation is a highly conserved process affecting over one-third of all eukaryotic proteins. The enzymes primarily responsible for facilitating thiol-disulfide exchange are members of an expanding family of proteins known as protein...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | http://www.humgenomics.com/content/6/1/6 |
_version_ | 1817991053302562816 |
---|---|
author | Galligan James J Petersen Dennis R |
author_facet | Galligan James J Petersen Dennis R |
author_sort | Galligan James J |
collection | DOAJ |
description | <p>Abstract</p> <p>Enzyme-mediated disulfide bond formation is a highly conserved process affecting over one-third of all eukaryotic proteins. The enzymes primarily responsible for facilitating thiol-disulfide exchange are members of an expanding family of proteins known as protein disulfide isomerases (PDIs). These proteins are part of a larger superfamily of proteins known as the thioredoxin protein family (TRX). As members of the PDI family of proteins, all proteins contain a TRX-like structural domain and are predominantly expressed in the endoplasmic reticulum. Subcellular localization and the presence of a TRX domain, however, comprise the short list of distinguishing features required for gene family classification. To date, the <it>PDI</it> gene family contains 21 members, varying in domain composition, molecular weight, tissue expression, and cellular processing. Given their vital role in protein-folding, loss of PDI activity has been associated with the pathogenesis of numerous disease states, most commonly related to the unfolded protein response (UPR). Over the past decade, UPR has become a very attractive therapeutic target for multiple pathologies including Alzheimer disease, Parkinson disease, alcoholic and non-alcoholic liver disease, and type-2 diabetes. Understanding the mechanisms of protein-folding, specifically thiol-disulfide exchange, may lead to development of a novel class of therapeutics that would help alleviate a wide range of diseases by targeting the UPR.</p> |
first_indexed | 2024-04-14T01:07:00Z |
format | Article |
id | doaj.art-3f7372832c15444eb4a2a41e55826e5f |
institution | Directory Open Access Journal |
issn | 1479-7364 |
language | English |
last_indexed | 2024-04-14T01:07:00Z |
publishDate | 2012-07-01 |
publisher | BMC |
record_format | Article |
series | Human Genomics |
spelling | doaj.art-3f7372832c15444eb4a2a41e55826e5f2022-12-22T02:21:11ZengBMCHuman Genomics1479-73642012-07-0161610.1186/1479-7364-6-6The human protein disulfide isomerase gene familyGalligan James JPetersen Dennis R<p>Abstract</p> <p>Enzyme-mediated disulfide bond formation is a highly conserved process affecting over one-third of all eukaryotic proteins. The enzymes primarily responsible for facilitating thiol-disulfide exchange are members of an expanding family of proteins known as protein disulfide isomerases (PDIs). These proteins are part of a larger superfamily of proteins known as the thioredoxin protein family (TRX). As members of the PDI family of proteins, all proteins contain a TRX-like structural domain and are predominantly expressed in the endoplasmic reticulum. Subcellular localization and the presence of a TRX domain, however, comprise the short list of distinguishing features required for gene family classification. To date, the <it>PDI</it> gene family contains 21 members, varying in domain composition, molecular weight, tissue expression, and cellular processing. Given their vital role in protein-folding, loss of PDI activity has been associated with the pathogenesis of numerous disease states, most commonly related to the unfolded protein response (UPR). Over the past decade, UPR has become a very attractive therapeutic target for multiple pathologies including Alzheimer disease, Parkinson disease, alcoholic and non-alcoholic liver disease, and type-2 diabetes. Understanding the mechanisms of protein-folding, specifically thiol-disulfide exchange, may lead to development of a novel class of therapeutics that would help alleviate a wide range of diseases by targeting the UPR.</p>http://www.humgenomics.com/content/6/1/6Disulfide bondThioredoxinCalsequestrinUPRUnfolded protein responseER stress |
spellingShingle | Galligan James J Petersen Dennis R The human protein disulfide isomerase gene family Human Genomics Disulfide bond Thioredoxin Calsequestrin UPR Unfolded protein response ER stress |
title | The human protein disulfide isomerase gene family |
title_full | The human protein disulfide isomerase gene family |
title_fullStr | The human protein disulfide isomerase gene family |
title_full_unstemmed | The human protein disulfide isomerase gene family |
title_short | The human protein disulfide isomerase gene family |
title_sort | human protein disulfide isomerase gene family |
topic | Disulfide bond Thioredoxin Calsequestrin UPR Unfolded protein response ER stress |
url | http://www.humgenomics.com/content/6/1/6 |
work_keys_str_mv | AT galliganjamesj thehumanproteindisulfideisomerasegenefamily AT petersendennisr thehumanproteindisulfideisomerasegenefamily AT galliganjamesj humanproteindisulfideisomerasegenefamily AT petersendennisr humanproteindisulfideisomerasegenefamily |